Treatment of Oral Thrush
For oral thrush, first-line treatment is fluconazole 100-200 mg daily for 7-14 days for moderate to severe cases, or topical options such as nystatin suspension (400,000-600,000 units four times daily) or clotrimazole troches (10 mg five times daily) for mild cases. 1
First-Line Treatment Options
For Mild Cases:
- Topical antifungal agents:
- Nystatin suspension: 4-6 mL (400,000-600,000 units) four times daily for 7-14 days 1, 2
- Administration technique: Place half the dose in each side of the mouth and retain as long as possible before swallowing
- Nystatin pastilles: 1-2 pastilles (200,000 units each) four times daily for 7-14 days 1
- Clotrimazole troches: 10 mg five times daily for 7-14 days 3, 1, 4
- Nystatin suspension: 4-6 mL (400,000-600,000 units) four times daily for 7-14 days 1, 2
For Moderate to Severe Cases:
- Systemic antifungal agents:
Treatment Algorithm Based on Severity and Patient Factors
For immunocompetent patients with mild disease:
- Start with topical agents (nystatin suspension or clotrimazole troches)
- Continue for 7-14 days or at least 48 hours after symptom resolution
For moderate to severe disease or immunocompromised patients:
- Fluconazole 100-200 mg daily for 7-14 days
- Consider longer duration for immunocompromised patients
For refractory cases:
Comparative Efficacy
Research shows fluconazole has superior efficacy compared to topical agents:
- Fluconazole demonstrated better clinical cure rates than clotrimazole troches in HIV patients 6
- Fluconazole showed 100% cure rate compared to 32% for nystatin in infants with oral thrush 7
- Patient compliance is significantly better with once-daily fluconazole compared to multiple daily doses of topical agents 6
Prevention of Recurrence
Implement strict oral hygiene measures 1:
- Brush teeth with soft toothbrush twice daily
- Clean dentures thoroughly and remove overnight
- Rinse mouth with alcohol-free mouthwash
- Maintain adequate hydration
For denture wearers:
- Disinfect dentures daily
- Consider denture replacement if ill-fitting 1
For patients using inhaled corticosteroids:
- Rinse mouth thoroughly after each use 1
For recurrent infections in high-risk patients:
- Consider chronic suppressive therapy with fluconazole (100-200 mg three times weekly) 1
Special Considerations
Immunocompromised patients (HIV, cancer, transplant recipients):
- May require longer treatment duration and closer follow-up
- Systemic therapy (fluconazole) often preferred over topical agents 1
Diabetic patients:
- Ensure adequate glycemic control
- May require more aggressive treatment 1
Elderly patients:
- More susceptible due to physiological changes, comorbidities, and medications 1
- Monitor for drug interactions with fluconazole
Patients on multiple medications:
Remember to confirm diagnosis with clinical examination and consider scraping for microscopic examination (KOH preparation) to confirm yeast forms in uncertain cases 1.